NervGen Pharma Corp. (NGEN) stock
NGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.96+0.14 (+7.69%)
Close on Nov 17, 2026Market cap $156.11MP/E –Yield –
NervGen Pharma operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -C$19.50M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -C$19.50M | – |
| FY2024 | Dec 31, 2024 | -C$16.84M | – |
See a number that looks wrong?